DEFERRED INCOME



Dollars in Millions	June 30, 2015		December 31, 2014
Alliances (Note 3)	$	1,480	$	1,493
Gain on sale-leaseback transactions	35		45
Other	91		399
Total deferred income	$	1,606	$	1,937

Current portion	$	939	$	1,167
Non-current portion	667		770

Alliances include unamortized amounts for upfront, milestone and other licensing receipts, revenue deferrals attributed to the Gilead alliance and deferred income for the undelivered elements of the diabetes business divestiture. Other deferrals included $300 million invoiced for Daklinza under an early access program in France as of December 31, 2014, that was deferred until final pricing was obtained from the French government in the second quarter of 2015.

Amortization of deferred income was $159 million and $174 million for the six months ended June 30, 2015 and 2014, respectively.